This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024 with a ceiling value of $1,716.65. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is December 9, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor and is a for-profit organization registered in the System for Award Management (SAM.gov). This contract award is likely part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which enables efficient government procurement of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/7/25, 9:43 AM